A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : IMRT / intensity-modulated radiotherapy

[Related PubMed/MEDLINE]
Total Number of Papers: 5672
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   IMRT  (>> Co-occurring Abbreviation)
Long Form:   intensity-modulated radiotherapy
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 10-Year Results of Therapeutic Ratio by Intensity-Modulated Radiotherapy Versus Two-Dimensional Radiotherapy in Patients with Nasopharyngeal Carcinoma. CI, FFS, HR, LFFS, NPC, OS
2019 18F-FDG-PET/CT-guided intensity-modulated radiotherapy for 42 FIGO III/IV ovarian cancer: A retrospective study. FIGO, KPS, OS, PFS
2019 A cross sectional study in cognitive and neurobehavioral impairment in long-term nasopharyngeal cancer survivors treated with intensity-modulated radiotherapy. FrSBe, MoCA, NPC
2019 A dosimetric study on the use of 3D-printed customized boluses in photon therapy: A hydrogel and silica gel study. CI, HI
2019 A feasibility study for predicting optimal radiation therapy dose distributions of prostate cancer patients from patient anatomy using deep learning. OAR, PTV
2019 A feasibility study of independent verification of dose calculation for Vero4DRT using a Clarkson-based algorithm. AAPM, CT, SBRT, TG114, TPS
2019 A Model-Based Approach to Predict Short-Term Toxicity Benefits With Proton Therapy for Oropharyngeal Cancer. NTCP, PBT
2019 A Phase II Study Evaluating Bone Marrow-Sparing, Image-guided Pelvic Intensity-Modulated Radiotherapy (IMRT) With Cesium-131 Brachytherapy Boost, Adjuvant Chemotherapy, and Long-Term Hormonal Ablation in Patients With High Risk, Nonmetastatic Prostate Cancer. ADT, BRFS, Cs, DFS, GI, GU, OS
2019 A scoring system predicting acute radiation dermatitis in patients with head and neck cancer treated with intensity-modulated radiotherapy. HNC, LRA, RPA, VMAT
10  2019 A trial for EBT3 film without batch-specific calibration using a neural network. ANN
11  2019 Acute and Late Toxicity after Moderate Hypofractionation with Simultaneous Integrated Boost (SIB) Radiation Therapy for Prostate Cancer. A Single Institution, Prospective Study. GI, GU, RTOG, SIB
12  2019 Adensity assignment method for dose monitoring in head-and-neck radiotherapy. DAM, PGs
13  2019 An in-silico quality assurance study of contouring target volumes in thoracic tumors within a cooperative group setting. CTV, PTV, STAPLE, SWOG
14  2019 An investigation of clinical treatment field delivery verification using cherenkov imaging: IMRT positioning shifts and field matching. ICCD
15  2019 Analysis of a volumetric-modulated arc therapy (VMAT) single phase prostate template as a class solution. CP, OAR, RT, VMAT
16  2019 Automatic treatment planning based on three-dimensional dose distribution predicted from deep learning technique. DVH, OARs, PTVs
17  2019 Bimodal Radiotherapy with Active Raster-Scanning Carbon Ion Radiotherapy and Intensity-Modulated Radiotherapy in High-Risk Nasopharyngeal Carcinoma Results in Excellent Local Control. CIRT, CR, DPFS, LC, NPC, OS, PR, SD
18  2019 Brachytherapy: A critical component of primary radiation therapy for cervical cancer: From the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS). ABS, SBRT, SGO
19  2019 Brachytherapy: A critical component of primary radiation therapy for cervical cancer: From the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS). ABS, SBRT, SGO
20  2019 Cardiac-Sparing Whole Lung IMRT in Patients With Pediatric Tumors and Lung Metastasis: Final Report of a Prospective Multicenter Clinical Trial. AP, CS, RT, WLI
21  2019 Changes in plasma EBV-DNA and immune status in patients with nasopharyngeal carcinoma after treatment with intensity-modulated radiotherapy. EBV, NPC, Treg
22  2019 Clinical and Molecular Recursive Partitioning Analysis of High-grade Glioma Treated With IMRT. RTOG-RPA
23  2019 Commissioning of portal dosimetry using a novel method for flattening filter-free photon beam in a nontrue beam linear accelerator. EPID, FFF, GAI, MU, PD, SDD, SRS, VMAT
24  2019 Comparative effectiveness of intensity modulated radiation therapy to 3-dimensional conformal radiation in locally advanced lung cancer: pathological and clinical outcomes. 3D-CRT, DFS, LC, OS, pCR, PTV
25  2019 Comparison of biological-based and dose volume-based intensity-modulated radiotherapy plans generated using the same treatment planning system. DV, EUD, RT, TPSs
26  2019 Comparison of outcome and toxicity of postoperative intensity-modulated radiation therapy with two-dimensional radiotherapy in patients with soft tissue sarcoma of extremities and trunk. DFS, DMFS, LRFS, OS, STS
27  2019 Comparison of treatment plans for ahigh-field MRI-linac and aconventional linac for esophageal cancer. MRI, VMAT
28  2019 Comparison of volumetric-modulated arc therapy and intensity-modulated radiation therapy prostate cancer plans accounting for cold spots. OAR, PTV, ROP, VMAT
29  2019 Complementary Relation Between the Improvement of Dose Delivery Technique and PTV Margin Reduction in Dose-Escalated Radiation Therapy for Prostate Cancer. CRT, NTCP, PTV
30  2019 Conventional radiotherapy and intensity-modulated radiotherapy in carcinoma vulva: An experience from a tertiary medical center of India. ---
31  2019 Cost and Cost-Effectiveness of Image Guided Partial Breast Irradiation in Comparison to Hypofractionated Whole Breast Irradiation. APBI, HWBI
32  2019 Deep learning for patient-specific quality assurance: Identifying errors in radiotherapy delivery by radiomic analysis of gamma images with convolutional neural networks. EPID, MLC, QA
33  2019 Definite chemoradiotherapy is a competent treatment option in FIGO stage IB2 cervical cancer compared with radical surgery +/- neoadjuvant chemotherapy. DFS, DMFS, FIGO, LRFFS, OS
34  2019 Depicting distant metastatic risk by refined subgroups derived from the 8th edition nasopharyngeal carcinoma TNM. AIC, C-index, DM, DMFS, NPC, RPA, TNM
35  2019 Development and validation of a decision support tool to select IMRT as radiotherapy treatment planning modality for patients with locoregionally advanced non-small cell lung cancers (NSCLC). NSCLC, PTV
36  2019 Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging. CNR2, EBRT, TMZ
37  2019 Dosimetric parameters associated with conductive or sensorineural hearing loss 5 years after intensity-modulated radiation therapy in nasopharyngeal carcinoma. CHL, Co, ET, IAC, ME, NPC, SNHL
38  2019 Dosimetric predictors of temporal lobe injury after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma: a competing risk study. AUC, CIF, NPC, SHR, TLI
39  2019 Dosimetry and Gastrointestinal Toxicity Relationships in a Phase II Trial of Pelvic Lymph Node Radiotherapy in Advanced Localised Prostate Cancer. CFRT, deltaM, HFRT, PLN
40  2019 Early and late side effects, dosimetric parameters and quality of life after proton beam therapy and IMRT for prostate cancer: a matched-pair analysis. CTCAE, GI, GU, OARs, PBT, PCa, QOL, RT
41  2019 Effectiveness of Intensity-Modulated Radiotherapy for Rectal Cancer Patients Treated With Neoadjuvant Concurrent Chemoradiotherapy: A Population-based Propensity Score-matched Analysis. 3DCRT, HR, LARC, nCCRT, SA, TCR
42  2019 Efficacy and Toxicity of IMRT-Based Simultaneous Integrated Boost for the Definitive Management of Positive Lymph Nodes in Patients with Cervical Cancer. GI, LNs, SIB
43  2019 Elective nodal irradiation provides a superior therapeutic modality for lymph node positivity esophageal squamous cell carcinoma patients receiving definitive radiotherapy versus involved-field irradiation. CI, ENI, ESCC, IFI, LN, OS, PSM
44  2019 Evaluation of positional accuracy of the Varian's exact-arm and retractable-arm support electronic portal imaging device using intensity-modulated radiotherapy graticule phantom. E-arm, EPID, R-arm, SIDs, TPS
45  2019 Evaluation of the Elekta Agility MLC performance using high-resolution log files. MLCs, RMSE, VMAT
46  2019 Excluding PTV from lung volume may better predict radiation pneumonitis for intensity modulated radiation therapy in lung cancer patients. AUC, DVH, MLD, NTCP, RP, Total Lung
47  2019 Exposure of remote organs and associated cancer risks from tangential and multi-field breast cancer radiotherapy. ---
48  2019 External beam accelerated partial breast irradiation: dosimetric assessment of conformal and three different intensity modulated techniques. APBI, PQI, SS, SW
49  2019 Feasibility of intensity-modulated radiotherapy to treat gastric cancer. BP, DVH, ITV, OAR, SM
50  2019 Femoral Fracture in Primary Soft-Tissue Sarcoma of the Thigh and Groin Treated with Intensity-Modulated Radiation Therapy: Observed versus Expected Risk. PMH, STS
51  2019 Five-year outcomes of sparing level IB in node-positive, human papillomavirus-associated oropharyngeal carcinoma: A safety and efficacy analysis. HPV, OPC, SMG
52  2019 Flattening filter free in intensity-modulated radiotherapy (IMRT) - Theoretical modeling with delivery efficiency analysis. FF, FFF, SBRT, VMAT
53  2019 Grading of MRI-detected skull-base invasion in nasopharyngeal carcinoma with skull-base invasion after intensity-modulated radiotherapy. DMFS, ESBI, LFFS, LSBI, NPC, OS, PFS
54  2019 Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery With Volumetric Image-guided Intensity Modulated Radiation Therapy. CHT, CT, DLBCL, ISRT, PFS
55  2019 Impact of modern radiotherapy techniques on survival outcomes for unselected patients with large volume non-small cell lung cancer. CCRT, NSCLC, PTV
56  2019 Impact of thoracic radiation therapy after chemotherapy on survival in extensive-stage small cell lung cancer: A propensity score-matched analysis. CHT, CR, ES-SCLC, OS, PFS, PR, SD, TRT
57  2019 Improvements in treatment planning calculations motivated by tightening IMRT QA tolerances. DVH, QA
58  2019 IMRT combined with S-1 concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a prospective phase II study. CCRT, DMFS, LANPC, LRFS, OS, PFS
59  2019 IMRT-based treatment of unknown primary malignancy of the head and neck: Outcomes and improved toxicity with decreased mucosal dose and larynx sparing. PEG
60  2019 Influence of 3D-CRT and conformal IMRT on thyroid function of patients with cervical and upper thoracic esophageal cancer and comparison of clinical efficacy. CI, Dmax, TSH
61  2019 Integrated skin flash planning technique for intensity-modulated radiation therapy for vulvar cancer prevents marginal misses and improves superficial dose coverage. ISF, RT
62  2019 Intensity modulated proton therapy (IMPT) - The future of IMRT for head and neck cancer. HNCs, IMPT
63  2019 Intensity Modulated Radiation Therapy Versus Volumetric Arc Radiation Therapy in the Treatment of Glioblastoma-Does Clinical Benefit Follow Dosimetric Advantage? GBM, TOT, VMAT
64  2019 Intensity-modulated proton therapy decreases dose to organs at risk in low-grade glioma patients: results of a multicentric in silico ROCOCO trial. IMPT, LGG, OARs, TOMO, VMAT
65  2019 Intensity-modulated radiation therapy of anal squamous cell carcinoma: Relationship between delineation quality and regional recurrence. ASCC, IF, LR, LRR, ML, OF, RR, RS
66  2019 Intensity-modulated radiation therapy with simultaneous integrated boost for locally advanced breast cancer: a prospective study on toxicity and quality of life. QOL
67  2019 Irradiated ears in nasopharyngeal carcinoma survivors: A review. NPC
68  2019 Japanese structure survey of radiation oncology in 2010. FTE, LINAC, RALS
69  2019 Long-Term Pulmonary Outcomes of a Feasibility Study of Inverse-Planned, Multibeam Intensity Modulated Radiation Therapy in Node-Positive Breast Cancer Patients Receiving Regional Nodal Irradiation. IMNs, RP
70  2019 Long-term results of intensity-modulated radiotherapy with three dose-fractionation regimens for localized prostate cancer. GI, GU, PSA
71  2019 Machine learning-based radiomic models to predict intensity-modulated radiation therapy response, Gleason score and stage in prostate cancer. ADC, AUC, GS, MRI, PCa, T2W
72  2019 Magnetic resonance imaging radiomic feature analysis of radiation-induced femoral head changes in prostate cancer radiotherapy. ADC, mpMRI, PCa
73  2019 Maximizing rectal dose sparing with hydrogel: A retrospective planning study. CRW, CT, RW, SOH, VMAT
74  2019 Minimum breast distance largely explains individual variability in doses to contralateral breast from breast-cancer radiotherapy. CB, MBD
75  2019 Modifiable risk factors for acute skin toxicity in adjuvant breast radiotherapy: Dosimetric analysis and review of the literature. CF, HF, RT
76  2019 Multi-institutional evaluation of end-to-end protocol for IMRT/VMAT treatment chains utilizing conventional linacs. AAPM, IROC, OSLD, QA, TG, VMAT
77  2019 Multi-institutional evaluation using the end-to-end test for implementation of dynamic techniques of radiation therapy in Thailand. VMAT
78  2019 NACT+IMRT versus NACT+IMRT+CCRT in locoregionally advanced NPC patients: a retrospective study. CCRT, CR, NACT, NPC, PR, RR, RT, SD
79  2019 Neoadjuvant image-guided helical intensity modulated radiotherapy of extremity sarcomas - a single center experience. IGRT, RT, STS
80  2019 Omitting Elective Irradiation of the Contralateral Retropharyngeal Nodes in Oropharyngeal Squamous Cell Carcinoma Treated with Intensity-modulated Radiotherapy. OS, RPLN
81  2019 Optimizing beam models for dosimetric accuracy over a wide range of treatments. MLCs, TPS, VMAT
82  2019 Origin of Locoregional Recurrences After Definitive Intensity-modulated Radiation Therapy (IMRT) for Laryngeal Cancer Determined Based on Follow-up PET/CT Imaging. GTV70, PET/CT, SCCA, SUV
83  2019 Outcome and prognostic factors following palliative craniospinal irradiation for leptomeningeal carcinomatosis. CSF, CSI, KPI, LC, NFS, OS, RT
84  2019 Outcomes After Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma. FFLTF, FFTF, MALT, OS, RT
85  2019 Outcomes and prognostic factors for patients with cervical esophageal cancer undergoing definitive radiotherapy or chemoradiotherapy. CCRT, CEC, CT, LRFFS, OS, PFS
86  2019 Outcomes of carotid-sparing IMRT for T1 glottic cancer: Comparison with conventional radiation. ConRT, OS
87  2019 Paranasal Sinus Invasion in Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy. AJCC, LFFS, MRI, NPC, OS
88  2019 Patterns of Local-Regional Failure After Intensity Modulated Radiation Therapy or Passive Scattering Proton Therapy With Concurrent Chemotherapy for Non-Small Cell Lung Cancer. ITV, LF, MF, PSPT, PTV, RF
89  2019 Penile bulb sparing in prostate cancer radiotherapy : Dose analysis of an in-house MRI system to improve contouring. EBRT, ERB, IBT, PB, PTV
90  2019 Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol. GBM, OS, RP2D, TMZ
91  2019 Physical and Dosimetric Aspect of Euromechanics Add-on Multileaf Collimator on Varian Clinac 2100 C/D. FWHM, MLC
92  2019 Positron emission tomography for staging locally advanced cervical cancer and assessing intensity modulated radiotherapy approach. HDR-BT, LACC, SIB
93  2019 Post-radiotherapy PET/CT for predicting treatment outcomes in head and neck cancer after postoperative radiotherapy. DM, HNSCC, LR, NPV, OS, PPV, RFS, RR
94  2019 Postradiation hypothyroidism in head and neck cancers: A Department of Veterans Affairs single-institution case-control dosimetry study. BED, RT, TSH, VA
95  2019 Practical clinical guidelines for contouring the trigeminal nerve (V) and its branches in head and neck cancers. ---
96  2019 Predictive gamma passing rate by dose uncertainty potential accumulation model. DUP, GPR, IM, SD, TPS
97  2019 Predictors of Patient-Reported Dysphagia Following IMRT Plus Chemotherapy in Oropharyngeal Cancer. CHT, HPV, IQR, MDADI, OPC
98  2019 Prognostic value of gross tumor regression and plasma Epstein Barr Virus DNA levels at the end of intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma. CR, DMFS, EBV, FFS, LRRFS, NPC, OS
99  2019 Properties of the anisotropy of dose contributions: A planning study on prostate cases. OAR, PTV, VMAT
100  2019 Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma. EBV, NPC